Bevacizumab vs steroids for brain radiation injury
Treatments studied
Part of Brain & nervous system, Cancer, Injuries & trauma clinical trials.
This trial tests if bevacizumab works better than steroids for people with brain swelling caused by radiation. If you have this condition and meet certain health requirements, you may join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have brain swelling from radiation, confirmed by your doctor
- Your daily steroid dose is 1 mg or less for the past 8 weeks
- You can understand study instructions and consent
- You have not had bevacizumab in the last 6 months
- Your life expectancy is more than 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether giving radiation therapy along with a combination of chemotherapy (cisplatin or carboplatin), an immunotherapy drug called adebrelimab, and a drug called bevacizumab can better treat triple-negative breast cancer that has spread to the brain. The goal is to see if this combination can shrink or control the brain tumors and improve outcomes.
This trial tests a drug called Avastin (bevacizumab) for people with brain swelling (radionecrosis) after radiation. It's for those whose symptoms don't get better with steroids or come back when steroids are reduced.
This trial compares two common steroid medications (methylprednisolone and dexamethasone) to see which one reduces swelling around brain tumors better during radiation therapy. If you have brain metastases and are planning radiation, this study might help find the best way to control symptoms like headaches or weakness.
This trial tests combining a drug called bevacizumab with a focused radiation treatment for people with lung cancer that has spread to the brain. It compares this to the standard radiation approach, and aims to see which better preserves memory and controls tumors.
This trial tests a combination of a drug that stops blood vessel growth (bevacizumab), immunotherapy, and focused radiation to treat melanoma that has spread to the brain and is causing symptoms. The goal is to see if this approach shrinks tumors and improves outcomes.
This trial tests a combination of immunotherapy (retifanlimab), a targeted drug (bevacizumab), and low-dose radiation for people whose glioblastoma has come back. The goal is to see if this treatment can help shrink or slow the tumor.
Hear when a new Radiation Necrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.